Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Toward a Living Meta-Framework for Evaluating Generative AI in Mental Health
ABSTRACT
The proliferation of evaluative approaches for generative artificial intelligence tools used for mental health purposes reflects much needed attention to safety, ethics, and emerging risks. However, limited alignment across frameworks complicates comparisons, slows progress toward shared goals, and provides little clarity for regulatory processes. The result is a fragmented field that lacks cohesive guidance as the technology and its real-world patterns of use continue to evolve. This Viewpoint synthesizes current evaluative approaches, outlines sources of divergence across existing frameworks, and identifies shared domains that could serve as anchors for coordinated development. We advocate for a living, flexible meta-framework maintained by a global, cross-sector consortium that can harmonize criteria, support consistent evaluation across jurisdictions, and adapt alongside scientific, clinical, and technological advances. Such a structure can strengthen safety, transparency, and methodological consistency while giving researchers, clinicians, developers, and policymakers a shared foundation for assessing generative artificial intelligence tools in mental health care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.